Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Strata Critical Medical's Revenue for the
three
months ended in Mar. 2026 was $67.4 Mil. Strata Critical Medical's average Accounts Receivable for the
three
months ended in Mar. 2026 was $39.8 Mil.
Hence, Strata Critical Medical's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.69.
Strata Critical Medical (NAS:SRTA) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Strata Critical Medical Receivables Turnover Related Terms
Strata Critical Medical Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Strata Critical Medical's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Strata Critical Medical Receivables Turnover Chart
SRTA vs CYH, CCRN, AUNA: Receivables Turnover Comparison
For the Medical Care Facilities subindustry, Strata Critical Medical's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Strata Critical Medical Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Strata Critical Medical's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Strata Critical Medical's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Strata Critical Medical (SRTA) has a Receivables Turnover of 1.69 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Strata Critical Medical and its competitors. According to the industry distribution chart, Strata Critical Medical ranks #338 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 51.3%.
Is Strata Critical Medical's Receivables Turnover too high?
Strata Critical Medical's current Receivables Turnover is 1.69. The Healthcare Providers & Services industry median Receivables Turnover is 7.75. Strata Critical Medical's value of 1.69 is 78.2% below this industry median. Based on the distribution chart, Strata Critical Medical ranks #338 out of 659 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Strata Critical Medical has a GF Score™ of 68/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Strata Critical Medical's Receivables Turnover compare to CYH and CCRN?
According to the Healthcare Providers & Services industry distribution chart, Strata Critical Medical ranks #338 out of 659 companies for Receivables Turnover. This places Strata Critical Medical in the lower half of its industry. The industry median Receivables Turnover is 7.75. Strata Critical Medical's value of 1.69 is 78.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.75, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Strata Critical Medical's current Receivables Turnover of 1.69 is 78.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Strata Critical Medical and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Strata Critical Medical's current Receivables Turnover is 1.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Strata Critical Medical stock overvalued right now?
Based on GuruFocus' analysis, Strata Critical Medical (SRTA) is currently considered Modestly Overvalued. The stock's GF Value™ is $4.48, compared to a current price of $5.15 — trading 15% above its estimated fair value. The current Receivables Turnover is 1.69 and 78.2% below the Healthcare Providers & Services industry median of 7.75. Strata Critical Medical's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Strata Critical Medical (SRTA), the current Receivables Turnover is 1.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Strata Critical Medical (SRTA) Overvalued in 2026?
Based on GuruFocus' analysis, Strata Critical Medical stock appears to be overvalued.
The current stock price of $5.15 is trading 15% above its estimated GF Value™ of $4.48.
GuruFocus considers Strata Critical Medical to be Modestly Overvalued.
Key valuation signals for SRTA:
Receivables Turnover: 1.69
GF Value™: $4.48 vs. price of $5.15 (15% above fair value)
Industry Position: 78.2% below the Healthcare Providers & Services median (#338 of 659)
No single metric tells the full story. See the SRTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.
68GF Score
Get the complete analysis for SRTA
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SRTA has been successfully added to your 
